DGMT StemCell supplies for E0787301 & E0221001
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Points of contact
-
- NCTR Acquisition Liaison nctracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration seeks stem cell supplies to support the PHCE project E0787301 and NTP project E0221001. This new requirement for biological product manufacturing falls under NAICS code 325414 and is classified as a medium-level supply procurement. The solicitation is estimated to be released on November 1, 2025, with an anticipated award date of January 1, 2026.
The estimated contract value ranges from $25,000 to $250,000. Interested vendors should direct inquiries to the Food and Drug Administration's Acquisition Liaison team at nctracquisitions@fda.hhs.gov. No small business set-asides are associated with this opportunity, allowing all qualified contractors to compete.
Forecast text
This contract is for medium supplies to support PHCE project E0787301 & NTP project E221001
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast